Umbilical Cord-Derived Mesenchymal Stromal Cell Therapy to Prevent the Development of Neurodevelopmental Disorders Related to Low Birth Weight

Scientists determined whether the systemic administration of umbilical cord-derived MSCs in the early postnatal period could attenuate neuroinflammation and thereby prevent the emergence of neurodevelopmental disorders.